Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Perhexiline injection and its preparing method

A technology for injection and coronary heart disease, which is applied in the field of injection for the treatment of coronary heart disease and ischemic cerebrovascular disease and its preparation, and the field of injection for the treatment of coronary heart disease and ischemic cerebrovascular disease, which can solve the problem of affecting the treatment of injection effect, reducing water solubility, precipitation, etc.

Inactive Publication Date: 2009-02-18
王锋
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The traditional preparation method of the injection is to mix Danshen and Chuanxiong decoction pieces together for three times of water extraction and secondary alcohol precipitation, then adjust the pH for acidification treatment to obtain Xinnaoning injection (CN1457784A) composed of Danshen and Chuanxiong extracts. Although Ligustrazine can be made into salt to increase its water solubility, but the main active ingredients in Salvia miltiorrhiza, such as salvianolic acid, salvianolic acid A, salvianolic acid C, etc., will reduce the water solubility under acidic conditions. properties, and even precipitate, so that the curative effect of the injection prepared by this method is affected. At the same time, the dry slices are extracted with water for 3 times, and the active ingredients cannot be extracted completely. , Ligustrazine and other components in Chuanxiong can not be completely extracted, but also make the phenolic esters in Chuanxiong, such as ligustilide, dimer ligustilide, chrysophanol, caffeic acid, protocatechuic acid , ferulic acid, etc. cannot be completely extracted; the type and content of active ingredients in the injection are reduced, which directly affects the therapeutic effect of the prepared injection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0017] 1. Salvia miltiorrhiza and Chuanxiong are harvested in different harvest seasons, and they are all processed as follows: cut off the clean reed head, wash the outer skin and sediment with water, dry the water on the surface, and immediately cut into 0.3-0.5cm thick Thin slices, thinly spread and put on plates, put into the freezer, slowly cool down to -24—-32°C within 2 hours, and continue to freeze for 3 hours. Take it out and rest at room temperature for 3 hours, transfer it to a vacuum drying cabinet, and dry it in a low-temperature vacuum at a pressure of 10.7-16.0 Pa and a temperature lower than 50°C, so that the water content in the decoction pieces is reduced to below 5%, take it out and store it separately and sealed for later use .

[0018] 2. Take 1000g of fresh danshen freeze-dried decoction pieces, extract by percolation with hot water at 90°C, control the percolation speed until the extraction is complete to obtain 7000ml of leachate, heat and concentrate t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a Guanxinning injection for effectively curing coronary heart disease and ischemic cerebrovascular disease. It is characterized by that said injection is basically formed from tanshinone, salvia phenol acid matter, liguistrazine and ligusticum pherol acid ester matter. Besides, said invention also provides its preparation method by utilizing fresh salvia root and ligusticum root and its concrete steps. It is characterized by that the invented injection not only contains tanshinone II A and ligustrazine, but also contains cryptotanshinone, tanshinone I, salvia phenol acid matter and ligusticum phenol acid ester matter.

Description

technical field [0001] The invention relates to an injection for treating coronary heart disease and ischemic cerebrovascular disease and a preparation method thereof, in particular to an injection for treating coronary heart disease and ischemic cerebrovascular disease prepared by extracting salvia miltiorrhiza and Chuanxiong as raw materials Liquid belongs to the field of traditional Chinese medicine. Background technique [0002] Most of the injections currently on the market for the treatment of coronary heart disease and ischemic cerebrovascular disease are composed of Danshen and Chuanxiong. They are effective in treating coronary heart disease and ischemic cerebrovascular disease, and are one of the commonly used traditional Chinese medicine injections in clinic. The traditional preparation method of the injection is to mix Danshen and Chuanxiong decoction pieces together for three times of water extraction and secondary alcohol precipitation, then adjust the pH for a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4965A61K36/53A61P9/10A61K31/12A61K31/343A61K31/365A61K31/19
Inventor 郭东宇
Owner 王锋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products